24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cancer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:10
U.S. strike signals Iran’s oil lifeline is no longer untouchable
20:41
Why did Zim’s CEO sell $40 million in shares before the $4.2 billion Hapag-Lloyd deal?
14:59
Wiz CEO Assaf Rappaport’s tech group to acquire Israeli broadcaster Reshet 13 from Len Blavatnik
13:13
“Iran is attempting an inflationary attack on the American consumer, raising fuel prices to create political pressure to end the war”
More stories
Buzz
Most popular
Daily
Weekly
1
Fresh Fund founder Zaki Djemal dies suddenly
2
Wiz billionaires forming private family office to manage proceeds from $32 billion Google exit
3
“Within 10 years, there will be at least 10 more Israeli companies like Wiz”
4
One-year-old AI startup Wonderful raises $150 million Series B at $2 billion valuation
5
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
More news
Cancer
11 stories about Cancer
Pharma Company BioCanCell Raises $25 million, Plans to Go Public in the U.S.
23.01.18
|
Asaf Shalev
The company said it will use the funding for clinical trials of BC-819, a drug being designed to treat early stage bladder cancer
Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall
16.01.18
|
Zohar Shahar Levy
Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights
Immunologists Exchange Verbal Blows in Legal Fight Over Kite Pharma Windfall
26.12.17
|
Zohar Shahar Levy
In August, Gilead Science bought anti-cancer treatment company Kite Pharma for $11.9 billion. Two Israeli scientists involved in the early research that led to the company’s breakthrough are now quarreling over patent royalty payments
Gilead Builds on Kite Pharma Acquisition, Buys Second CAR-T Therapy Company
10.12.17
|
Lilach Baumer
California-based Cell Design Labs will be acquired in a deal valued at up to $567 million
Pharma Veteran Julian Adams takes Helm at Gamida Cell
21.11.17
|
Lilach Baumer
The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
VBL Therapeutics Aims to Raise $18.75 Million in Public Offering
20.11.17
|
Lilach Baumer
The cancer treatment company announced an offering of 2.5 million shares last week
Pontifax Leads $9.5 Funding Round for Biopharmaceutical Company ArQule
19.11.17
|
CTech
Nasdaq-listed ArQule develops treatments for cancer and rare diseases
Generic Focus made Kite Pharma Founder Leave Teva
13.11.17
|
Dror Reich
Founder of cancer treatment company sold to Gilead Sciences for $12 billion, says Gilead wants “to crack the cancer market"
Cancer Treatment Company Negotiating $20-25 Million Capital Injection
29.10.17
|
Lilach Baumer
The potential investors condition the investment on delisting BioCanCell from the Tel Aviv Stock Exchange
Kite Pharma’s Cancer Drug Gets Regulatory Nod
19.10.17
|
Lilach Baumer
The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000
Kite Pharma Sale Triggers Scientist Quarrel
02.10.17
|
Zohar Shahar Levy
Zelig Eshhar who patented the company’s core technology is now being sued by his former PhD student and current pharma entrepreneur
Previous Articles